wegovy glp-1 agonist Agonists: A Comprehensive Overview Novo Nordisk launches Wegovy weight-loss

Mathi SK, Chan Y, Li X, and Wheeler MB

doi: 10.1016/j.mcna.2020.08.018

For CPG / Food and Beverage Manufacturers: Less is more (again): Weve all heard the phrase less is more. However, a trip down the grocery aisle may tell you the opposite

32 Fortunately, successful introduction of GLP-1 drugs into clinical practice has facilitated more detailed study of GLP-1 effects on bone health in the human setting ( Figure 3 )

The recommended dosing schedule starts at 1.5 mg for the first month, increases to 4 mg in the second month, and then jumps to 9 mg before eventually reaching 25 mgthe highest dose (and the one used in the study mentioned above)